Summary

The global Contact-lens Induced Infection market size was US$ 513 million in 2025 and is forecast to reach a readjusted size of US$ 713 million by 2032 with a CAGR of 4.9% during the forecast period 2026-2032.
Contact lens-induced infection refers to an eye infection caused by the improper use, handling, or care of contact lenses. Bacteria, fungi, or parasites can contaminate the lenses, leading to infections such as keratitis, which affects the cornea. Symptoms may include eye redness, pain, blurred vision, discharge, and sensitivity to light. Risk factors include wearing lenses for extended periods, sleeping in them, or failing to clean and store them properly. Prompt medical treatment is crucial to prevent serious complications, including vision loss.
In 2025, the North America Contact-lens Induced Infection market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Contact-lens Induced Infection include Alcon, Bausch + Lomb, AbbVie, Novartis International, Pfizer, Merck & Co., Santen Pharmaceutical, Teva Pharmaceutical, Roche Holding, Shionogi, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Contact-lens Induced Infection market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Alcon
Bausch + Lomb
AbbVie
Novartis International
Pfizer
Merck & Co.
Santen Pharmaceutical
Teva Pharmaceutical
Roche Holding
Shionogi
Kowa Company
Otsuka Pharmaceutical
AstraZeneca
Hikma Pharmaceuticals
Dr. Reddy’s Laboratories
Segment by Type
Antibiotics
Corticosteroids
Anti-inflammatory Drugs
NSAIDs
Other
Segment by Application
Hospitals
Ophthalmology Clinics
Retail Pharmacy
Other
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Contact-lens Induced Infection market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Contact-lens Induced Infection value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Antibiotics
1.2.3 Corticosteroids
1.2.4 Anti-inflammatory Drugs
1.2.5 NSAIDs
1.2.6 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Ophthalmology Clinics
1.3.4 Retail Pharmacy
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contact-lens Induced Infection Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Contact-lens Induced Infection Market Share by Revenue, by Region (2021-2026)
2.4 Global Contact-lens Induced Infection Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Contact-lens Induced Infection Market Size and Prospective (2021-2032)
2.5.2 Europe Contact-lens Induced Infection Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Contact-lens Induced Infection Market Size and Prospective (2021-2032)
2.5.4 Latin America Contact-lens Induced Infection Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Contact-lens Induced Infection Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Contact-lens Induced Infection Historical Market Size by Type (2021-2026)
3.2 Global Contact-lens Induced Infection Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Contact-lens Induced Infection
4 Breakdown Data by Application
4.1 Global Contact-lens Induced Infection Historical Market Size by Application (2021-2026)
4.2 Global Contact-lens Induced Infection Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Contact-lens Induced Infection Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Contact-lens Induced Infection Players by Revenue (2021-2026)
5.1.2 Global Contact-lens Induced Infection Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Contact-lens Induced Infection Revenue
5.4 Global Contact-lens Induced Infection Market Concentration Analysis
5.4.1 Global Contact-lens Induced Infection Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Contact-lens Induced Infection Revenue in 2025
5.5 Global Key Players of Contact-lens Induced Infection Head Offices and Areas Served
5.6 Global Key Players of Contact-lens Induced Infection, Product and Application
5.7 Global Key Players of Contact-lens Induced Infection, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Contact-lens Induced Infection Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Contact-lens Induced Infection Market Size by Type (2021-2026)
6.1.2.2 North America Contact-lens Induced Infection Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Contact-lens Induced Infection Market Size by Application (2021-2026)
6.1.3.2 North America Contact-lens Induced Infection Market Share by Application (2021-2026)
6.1.4 North America Contact-lens Induced Infection Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Contact-lens Induced Infection Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Contact-lens Induced Infection Market Size by Type (2021-2026)
6.2.2.2 Europe Contact-lens Induced Infection Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Contact-lens Induced Infection Market Size by Application (2021-2026)
6.2.3.2 Europe Contact-lens Induced Infection Market Share by Application (2021-2026)
6.2.4 Europe Contact-lens Induced Infection Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Contact-lens Induced Infection Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Contact-lens Induced Infection Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Contact-lens Induced Infection Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Contact-lens Induced Infection Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Contact-lens Induced Infection Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Contact-lens Induced Infection Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Contact-lens Induced Infection Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Contact-lens Induced Infection Market Size by Type (2021-2026)
6.4.2.2 Latin America Contact-lens Induced Infection Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Contact-lens Induced Infection Market Size by Application (2021-2026)
6.4.3.2 Latin America Contact-lens Induced Infection Market Share by Application (2021-2026)
6.4.4 Latin America Contact-lens Induced Infection Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Contact-lens Induced Infection Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Contact-lens Induced Infection Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Contact-lens Induced Infection Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Contact-lens Induced Infection Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Contact-lens Induced Infection Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Contact-lens Induced Infection Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Alcon
7.1.1 Alcon Company Details
7.1.2 Alcon Business Overview
7.1.3 Alcon Contact-lens Induced Infection Introduction
7.1.4 Alcon Revenue in Contact-lens Induced Infection Business (2021-2026)
7.1.5 Alcon Recent Development
7.2 Bausch + Lomb
7.2.1 Bausch + Lomb Company Details
7.2.2 Bausch + Lomb Business Overview
7.2.3 Bausch + Lomb Contact-lens Induced Infection Introduction
7.2.4 Bausch + Lomb Revenue in Contact-lens Induced Infection Business (2021-2026)
7.2.5 Bausch + Lomb Recent Development
7.3 AbbVie
7.3.1 AbbVie Company Details
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Contact-lens Induced Infection Introduction
7.3.4 AbbVie Revenue in Contact-lens Induced Infection Business (2021-2026)
7.3.5 AbbVie Recent Development
7.4 Novartis International
7.4.1 Novartis International Company Details
7.4.2 Novartis International Business Overview
7.4.3 Novartis International Contact-lens Induced Infection Introduction
7.4.4 Novartis International Revenue in Contact-lens Induced Infection Business (2021-2026)
7.4.5 Novartis International Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Details
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Contact-lens Induced Infection Introduction
7.5.4 Pfizer Revenue in Contact-lens Induced Infection Business (2021-2026)
7.5.5 Pfizer Recent Development
7.6 Merck & Co.
7.6.1 Merck & Co. Company Details
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Contact-lens Induced Infection Introduction
7.6.4 Merck & Co. Revenue in Contact-lens Induced Infection Business (2021-2026)
7.6.5 Merck & Co. Recent Development
7.7 Santen Pharmaceutical
7.7.1 Santen Pharmaceutical Company Details
7.7.2 Santen Pharmaceutical Business Overview
7.7.3 Santen Pharmaceutical Contact-lens Induced Infection Introduction
7.7.4 Santen Pharmaceutical Revenue in Contact-lens Induced Infection Business (2021-2026)
7.7.5 Santen Pharmaceutical Recent Development
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Details
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Contact-lens Induced Infection Introduction
7.8.4 Teva Pharmaceutical Revenue in Contact-lens Induced Infection Business (2021-2026)
7.8.5 Teva Pharmaceutical Recent Development
7.9 Roche Holding
7.9.1 Roche Holding Company Details
7.9.2 Roche Holding Business Overview
7.9.3 Roche Holding Contact-lens Induced Infection Introduction
7.9.4 Roche Holding Revenue in Contact-lens Induced Infection Business (2021-2026)
7.9.5 Roche Holding Recent Development
7.10 Shionogi
7.10.1 Shionogi Company Details
7.10.2 Shionogi Business Overview
7.10.3 Shionogi Contact-lens Induced Infection Introduction
7.10.4 Shionogi Revenue in Contact-lens Induced Infection Business (2021-2026)
7.10.5 Shionogi Recent Development
7.11 Kowa Company
7.11.1 Kowa Company Company Details
7.11.2 Kowa Company Business Overview
7.11.3 Kowa Company Contact-lens Induced Infection Introduction
7.11.4 Kowa Company Revenue in Contact-lens Induced Infection Business (2021-2026)
7.11.5 Kowa Company Recent Development
7.12 Otsuka Pharmaceutical
7.12.1 Otsuka Pharmaceutical Company Details
7.12.2 Otsuka Pharmaceutical Business Overview
7.12.3 Otsuka Pharmaceutical Contact-lens Induced Infection Introduction
7.12.4 Otsuka Pharmaceutical Revenue in Contact-lens Induced Infection Business (2021-2026)
7.12.5 Otsuka Pharmaceutical Recent Development
7.13 AstraZeneca
7.13.1 AstraZeneca Company Details
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Contact-lens Induced Infection Introduction
7.13.4 AstraZeneca Revenue in Contact-lens Induced Infection Business (2021-2026)
7.13.5 AstraZeneca Recent Development
7.14 Hikma Pharmaceuticals
7.14.1 Hikma Pharmaceuticals Company Details
7.14.2 Hikma Pharmaceuticals Business Overview
7.14.3 Hikma Pharmaceuticals Contact-lens Induced Infection Introduction
7.14.4 Hikma Pharmaceuticals Revenue in Contact-lens Induced Infection Business (2021-2026)
7.14.5 Hikma Pharmaceuticals Recent Development
7.15 Dr. Reddy’s Laboratories
7.15.1 Dr. Reddy’s Laboratories Company Details
7.15.2 Dr. Reddy’s Laboratories Business Overview
7.15.3 Dr. Reddy’s Laboratories Contact-lens Induced Infection Introduction
7.15.4 Dr. Reddy’s Laboratories Revenue in Contact-lens Induced Infection Business (2021-2026)
7.15.5 Dr. Reddy’s Laboratories Recent Development
8 Contact-lens Induced Infection Market Dynamics
8.1 Contact-lens Induced Infection Industry Trends
8.2 Contact-lens Induced Infection Market Drivers
8.3 Contact-lens Induced Infection Market Challenges
8.4 Contact-lens Induced Infection Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer